EMEA confirms withdrawal recommendation for dextropropoxyphene
This article was originally published in Scrip
Executive Summary
The European Medicines Agency has recommended that all non-parenteral forms of medicines containing the analgesic dextropropoxyphene be withdrawn because their risks – particularly the possibility of fatal overdose – outweigh their benefits.